| Pharmaceutical active ingredients: |
| Filgrastim (R-Methug-CSF) |
| Available forms, composition and doses of Neupogen Singleject: |
| Injectable; Injection; Filgrastim (R-Methug-CSF) 30 MUInjectable; Injection; Filgrastim (R-Methug-CSF) 48 MU |
| Neupogen Singleject medical category: |
| Human:Granulocyte colony-stimulating factorsHematopoietic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L03AA02 - Filgrastim |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Amgen |
| Related documents and information about Neupogen Singleject: |
| Neupogen prescribing information (PDF) |